Faus & Moliner participates in the 66 Congress of the Spanish Society of Hospital Pharmacy
Jordi Faus gives a presentation on the legal challenges raised by nanodrugs
Innovations and challenges in nanomedicine have been the subject of a session held within the framework of the 66th Congress of the Spanish Society of Hospital Pharmacy. The table was moderated by José Luis Poveda and Mª José Alonso (University of Santiago de Compostela), José Manuel Martinez Sesmero (Hospital Clínico San Carlos) and Jordi Faus... Read More
Global Legal Insights to: Pricing & Reimbursement 2021
Global Legal Group
The fourth edition of Pricing & Reimbursement has been recently published and just like last year Jordi Faus, with the collaboration of Lluís Alcover and Joan Carles Bailach, has been in charge of the chapter dedicated to pricing and reimbursement in Spain. GLI Pricing & Reimbursement includes the following sections for each of the 18... Read More
Ofertas a hospitales ante la aparición de genéricos o biosimilares y la definición de mercado relevante
CUADERNOS DE DERECHO FARMACÉUTICO, NUM. 76, JULY-SEPTEMBER 2021
On April 20, 2021, the Spanish Competition Authority decided to take no further action against a complaint filed by Amgen against Abbvie for an alleged abuse of a dominant position contrary to articles 2 of the Spanish Law on Competition and 102 of the TFEU. The alleged abusive practice consisted in the implementation of a... Read More
Sobre el ‘Informe Montserrat’
El Global
Busquen 30 minutos esta semana. En serio, encuéntrenlos y lean con calma el Informe aprobado por amplia mayoría en la Comisión de Medio Ambiente, Salud Pública y Seguridad Alimentaria del Parlamento Europeo, del cual ha sido ponente Dolors Montserrat. Antes de hacerlo, un apunte previo: la autora es natural de Barcelona, licenciada en derecho, ejerció como... Read More
Mejorar la información al paciente
El Global
Un paciente bien informado es un activo para la sociedad en su conjunto. A esta tajante conclusión llegó, hace ya casi 20 años, el High Level Group del G10, consciente del gran valor sociosanitario que tiene la información al paciente, también en lo que se refiere a la información sobre medicamentos. En el seno de... Read More
Faus & Moliner, the best Life Sciences Law Firm at the Sixth Edition of the Awards granted by Expansión Jurídico 2021
The award ceremony was held at Complejo Duques de Pastrana in Madrid
Faus & Moliner has been recognized for the third consecutive year as the best Law Firm in Life Sciences in Spain at the Sixth Edition of the Awards granted by Expansión Jurídico. The objective of this award is to recognize the work of lawyers and law firms that have made a remarkable contribution to the... Read More
Del “Just-in-time” al “Just-in-case”
El Global
El pasado mes de marzo, la Comisión lanzó la iniciativa de revisión de la legislación farmacéutica europea, dado a cualquier interesado la oportunidad de presentar aportaciones al documento “Combined evaluation roadmap/inception impact assessment). Se recibieron 173 comentarios, incluido el que formulamos desde Faus & Moliner. Todos ellos pueden consultarse en la página web de la... Read More
Delimitando la venta online de medicamentos
El Global
La Audiencia Nacional dictó una sentencia el pasado 6 de julio de 2021 que despertó mi curiosidad por lo impactantes que eran los hechos que relataba. La sentencia nos sitúa ante un caso en el que una fundación, establecida fuera de la UE, ofrecía a través de su página web servicios de información sobre tratamientos... Read More
Advertising of authorised medicinal products
Judgement of the High Court of Justice of the Basque Country of 30 June 2021
Capsulas Nº 219
Background This judgement is well-known. Farmaindustria filed an appeal against an Order governing medical visits in the Basque Country. The appeal was filed because, inter alia, Farmaindustria considered that the Order did not allow the advertising of authorized medicinal products for which a national price and reimbursement decision was pending. The Judgement concludes that neither... Read More
Precautionary measures regarding access to unauthorized medicinal products
Orders of the Contentious Administrative Court I of Castellon de la Plana of 10, 13 and 27 August 2021
Capsulas Nº 219
Background In August 2021, following a request from the relatives of a patient in serious condition for Covid-19, a Spanish Court adopted precautionary measures forcing the application of an unauthorized ozone therapy in a public hospital. Whatever one’s views about such type of treatment, these Court orders are relevant to the extent they deal with... Read More